SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

EU Approves Extended Libtayo Cancer Dosing

Regeneron said the EU approved extended dosing for its Libtayo cancer treatment.

REGN

Related stories